Of course, even though more detailed pharmacokinetics approaches should be needed, these data suggested J2 as a possible candidate drug for sensitization as combination with conventional anticancer drugs in HSP27 overexpressed lung cancer patients. Here, HSPB1 is linked to lung cancer.